Pancreatic Cancer Research

ResearcherChina Medical UniversityNo recent work listed

Minjie Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0404-7098; OpenAlex author ID A5084063375. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Screening of an annexin-A2-targeted heptapeptide for pancreatic adenocarcinoma localization. Last author DOI 10.1002/1878-0261.13352↗
  2. LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis. Last author DOI 10.4251/wjgo.v12.i11.1272↗
  3. Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer. Co-author DOI 10.7150/jca.47877↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Miao He · 2 shared papers, 2020–2023 · strength 0.30
  2. Yue Fan · 1 shared paper, 2023 · strength 0.17
  3. Heyao Ma · 1 shared paper, 2023 · strength 0.17
  4. Lei Zhao · 1 shared paper, 2023 · strength 0.17
  5. Jinnian Ge · 1 shared paper, 2020 · strength 0.16
  6. Chunlin Ge · 1 shared paper, 2020 · strength 0.16
  7. Lin Wang · 1 shared paper, 2020 · strength 0.13
  8. Lin Zhao · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.